Literature DB >> 7657110

Intestinal B-cell isotype response in relation to local bacterial load: evidence for immunoglobulin A subclass adaptation.

K Kett1, K Baklien, A Bakken, J G Kral, O Fausa, P Brandtzaeg.   

Abstract

BACKGROUND & AIMS: In experimental animals, the indigenous microbiota modulates mucosal immunity. In humans, such direct evidence is scarce. The aim of this study was to examine the effect of intestinal bacteria on the local immunoglobulin (Ig) response.
METHODS: The numbers of IgA-, IgM-, and IgG-producing immunocytes per defined mucosal length unit were determined, and the local IgA subclass response was studied using immunohistochemistry in jejunal segments from adults with bacterial overgrowth and in sterile ileal urinary conduits from children.
RESULTS: The ileal bladder mucosa showed atrophy, but the number of immunocytes only tended to be decreased. The jejunal segments with bacterial overgrowth showed minor histological changes; the numbers of IgA and IgG immunocytes were fairly normal, whereas the number of IgM immunocytes was significantly reduced (P < 0.05) (12 cells/U) compared with control mucosa (24 cells/U). The number of IgA2 immunocytes was significantly decreased (P < 0.01) in ileal conduits (7 cells/U or 30% of total IgA) but increased (P < 0.05) in jejunal segments with bacterial overgrowth (42 cells/U or 43% of total IgA) compared with normal ileum (15 cells/U or 40% of total IgA) and jejunum (24 cells/U or 23% of total IgA).
CONCLUSIONS: An association exists between bacterial load and IgA subclass production. An increase in IgA2 may enhance mucosal protection and probably reflects immunomodulation caused by lipopolysaccharides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657110     DOI: 10.1016/0016-5085(95)90389-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

Review 1.  Unsolved mysteries of intestinal M cells.

Authors:  C Nicoletti
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 2.  Probiotics and immune response.

Authors:  Stephanie Blum; Dirk Haller; Andrea Pfeifer; Eduardo J Schiffrin
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

3.  Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment.

Authors:  Virmeet V. Singh; Phillip P. Toskes
Journal:  Curr Treat Options Gastroenterol       Date:  2004-02

Review 4.  Regulation of mucosal IgA responses: lessons from primary immunodeficiencies.

Authors:  Andrea Cerutti; Montserrat Cols; Maurizio Gentile; Linda Cassis; Carolina M Barra; Bing He; Irene Puga; Kang Chen
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

Review 5.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

Review 6.  Innate signaling networks in mucosal IgA class switching.

Authors:  Alejo Chorny; Irene Puga; Andrea Cerutti
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

7.  The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific.

Authors:  Julia Benckert; Nina Schmolka; Cornelia Kreschel; Markus Josef Zoller; Andreas Sturm; Bertram Wiedenmann; Hedda Wardemann
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

8.  Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluids.

Authors:  Sari H Pakkanen; Jussi M Kantele; Zina Moldoveanu; Spencer Hedges; Miikka Häkkinen; Jiri Mestecky; Anu Kantele
Journal:  Clin Vaccine Immunol       Date:  2010-01-20

Review 9.  The regulation of IgA class switching.

Authors:  Andrea Cerutti
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

10.  Pediatric small intestine bacterial overgrowth in low-income countries.

Authors:  Jeffrey R Donowitz; William A Petri
Journal:  Trends Mol Med       Date:  2014-11-15       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.